ION Exchange (India) Limited (IONEXCHANG)
Please find attached revised Investor Presentation.
Investor Presentation - FY2027
- Company operates in 50+ countries with 200,000+ installations worldwide
- Strategic capacity expansions: 2X in Industrial Resins, 5X in Pharma Resins, 3X in Membrane Manufacturing
- Focus on sustainability with integrated acid recovery and circular manufacturing
- Diverse segment outlook: Treatment Solutions, Industrial Products, Lifecycle Services, Specialty Chemicals, Consumer Products
- Emphasis on digital solutions and service network expansion
- Human capital strength: 3,500+ professionals across 15+ countries
- Strong growth in Treatment Solutions and Consumer Products segments
- Operational excellence with expanded manufacturing and assembly facilities
- Commitment to innovation with advanced R&D centers and patents held
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 IONEXCHANG — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add IONEXCHANG to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on ION Exchange (India) Limited
Important.
The summary above is generated automatically from ION Exchange (India) Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.